Dizal (Jiangsu) Pharmaceutical Co., Ltd. (SHA:688192)
China flag China · Delayed Price · Currency is CNY
57.56
+5.56 (10.69%)
At close: May 21, 2026

SHA:688192 Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
26,77526,56417,23719,53016,03014,959
Market Cap Growth
9.03%54.11%-11.74%21.83%7.16%-
Enterprise Value
26,28825,70417,34218,89114,51814,805
Last Close Price
57.5657.6041.4747.8539.3737.01
PS Ratio
29.9533.1647.89213.94-1454.37
PB Ratio
21.6820.5086.1623.019.126.07
P/TBV Ratio
31.6429.60-50.5112.667.53
EV/Sales Ratio
29.4032.0848.18206.94-1439.37
Debt / Equity Ratio
1.170.965.790.480.050.04
Net Debt / Equity Ratio
-0.39-0.541.59-0.40-0.76-0.81
Net Debt / EBITDA Ratio
0.720.90-0.340.301.773.12
Net Debt / FCF Ratio
0.620.92-0.400.341.973.97
Asset Turnover
0.370.340.220.05-0.01
Inventory Turnover
1.080.840.280.54--
Quick Ratio
2.702.111.111.785.709.82
Current Ratio
2.822.221.272.035.939.96
Return on Equity (ROE)
-106.69%-102.76%-179.21%-84.98%-34.87%-37.83%
Return on Assets (ROA)
-18.86%-21.71%-37.81%-40.35%-20.52%-21.46%
Return on Capital Employed (ROCE)
-32.60%-40.60%-104.20%-110.20%-43.20%-26.60%
Earnings Yield
-2.49%-2.88%-4.91%-5.67%-4.59%-4.48%
FCF Yield
-2.94%-2.86%-4.57%-5.12%-4.22%-3.35%
Buyback Yield / Dilution
-9.73%-7.75%-1.83%-0.70%-12.29%-0.07%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.